Immunotherapy with anti‐G D2 monoclonal antibody in infants with high‐risk neuroblastoma
International Journal of Cancer · 15.01.2023 · 152 (2) · 259-266
DOI: 10.1002/ijc.34233 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 17.08.2022. Verfasst von Brian H Kushner und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Posterior Leukoencephalopathy Syndrome, Neuroblastoma, Antineoplastic Agents. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Anti‐G D2 monoclonal antibodies (mAb) improve the prognosis of high‐risk neuroblastoma (HR‐NB). Worldwide experience almost exclusively involves toddlers and older patients treated after multimodality or second‐line therapies, that is, many months postdiagnosis. In contrast, at our center, infants received anti‐G D2 mAbs because this immunotherapy started during or immediately after induction chemotherapy. We now report on the feasibility, safety, and long‐term survival in this vulnerable age group. Thirty‐three HR‐NB patients were 2.5× higher (~270 mg/m 2 /cycle) than 3F8, dinutuximab, and dinutuximab beta (70‐100 mg/m 2 /cycle). HR‐NB in infants proved to be highly curable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
ORCID-Profile: Brian H Kushner
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Kushner, B. H., Modak, S., Kramer, K., Basu, E. M., Iglesias-Cardenas, F., Roberts, S. S., & Cheung, N. V. (2023). Immunotherapy with anti‐G D2 monoclonal antibody in infants with high‐risk neuroblastoma. International Journal of Cancer, 152(2), 259-266. https://doi.org/10.1002/ijc.34233
Vancouver
Kushner BH, Modak S, Kramer K, Basu EM, Iglesias-Cardenas F, Roberts SS, et al. Immunotherapy with anti‐G D2 monoclonal antibody in infants with high‐risk neuroblastoma. International Journal of Cancer. 2023;152(2):259-266. doi:10.1002/ijc.34233
BibTeX
@article{Kushner2023,
author = {Kushner, Brian H and Modak, Shakeel and Kramer, Kim and Basu, Ellen M and Iglesias-Cardenas, Fiorella and Roberts, Stephen S and Cheung, Nai-Kong V},
title = {Immunotherapy with anti‐G D2 monoclonal antibody in infants with high‐risk neuroblastoma},
journal = {International Journal of Cancer},
year = {2023},
volume = {152},
number = {2},
pages = {259--266},
doi = {10.1002/ijc.34233}
}
EUVIMED